Navigation Links
HIV treatment use increases in the US
Date:9/3/2012

Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy (HAART) increased, and HIV-infected patients appeared to be less infectious and have healthier immune systems at death, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The study was nested in the NA-ACCORD (North American AIDS Cohort Collaboration on Research and Design), which is the largest cohort of HIV-infected adults in North America. The findings are published in the September 4 edition of Annals of Internal Medicine.

The study included more than 45,000 HIV-infected participants receiving clinical care for HIV. The study population was demographically similar to the U.S. population living with HIV, according to national surveillance data from the Centers for Disease Control and Prevention. Over the study period, the researchers found that the proportion of HIV-infected participants prescribed HAART increased 9 percentage points to 83 percent. During this time, the researchers also observed an increase in viral load suppression among those with HIV, regardless of treatment. Suppression of viral load reduces the likelihood of transmitting HIV to others. Among those taking HAART, the proportion with a suppressed viral load increased from 54 percent to 81 percent.

"This is good news for the HIV epidemic in the U.S., but there is room for improvement," said Keri N. Althoff, PhD, MPH, lead author of the study and assistant professor in the Bloomberg School's Department of Epidemiology. "We need to continue to focus on linking HIV-infected adults into care and effective treatment, not only for the individual's health, but to reduce the likelihood of transmission to others."

The analysis also found an increase in median CD4 count for participants who died from HIV during the study period. Median counts increased at the time of death
'/>"/>

Contact: Tim Parsons
tmparson@jhsph.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Lyme retreatment guidance may be flawed
2. WSU/USDA scientist creates test, treatment for malaria-like sickness in horses
3. RI Hospital: Use of PMP may increase demand for drug treatment, reduce painkiller abuse
4. Gene discovery could improve treatment for acute myeloid leukemia
5. Should high-dose interleukin-2 continue to be the treatment of choice for metastatic melanoma?
6. Powerful class of antioxidants may be potent Parkinsons treatment
7. ECGs administered by paramedics can speed treatment for severe heart attacks
8. Reorganizing brain could lead to new stroke, tinnitus treatments
9. OHSU discovery may lead to new treatment for ALS
10. Real-life spider men using protein found in venom to develop muscular dystrophy treatment
11. Transforming cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2014)... cannot move your eyes up, and you cannot lift your upper ... that your eyes look straight when they are rolled down in ... allow people a normal position of their head. In order to ... , In a paper published in the April 16 print issue ...
(Date:4/16/2014)... Division of Lawrence Berkeley National Laboratory (Berkeley Lab) and ... on the evolutionary design principles of cellular networks and ... has been named one of six recipients of the ... Ernest Moniz. The E.O. Lawrence Award, the Department of ...
(Date:4/16/2014)... Aktories and Dr. Panagiotis Papatheodorou from the Institute of Experimental ... have discovered the receptor responsible for smuggling the toxin of ... TpeL toxin, which is formed by C. perfringens , ... is very similar to the toxins of many other hospital ...
Breaking Biology News(10 mins):Researchers track down cause of eye mobility disorder 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 3Gate for bacterial toxins found 2
... microbes, called phytoplankton, by researchers at Woods Hole Oceanographic ... solved a ten-year-old mystery about the source of an ... decade ago scientists discovered a rare form of organic ... researchers surprised to find this form of phosphorus, called ...
... announced today, Wednesday 30th September, by a team of ... Light Source, could have a significant impact on the ... for worldwide agriculture. Published in the Journal ... by Dr Jing-Jiang Zhou and colleagues at the world,s ...
... SEPTEMBER 25, 2009 The American Society of ... U.S. Department of Agriculture to improve water quality in ... (NRCS) will implement this voluntary, incentive-based program. "Clean ... of crop production practices that have been developed by ...
Cached Biology News:Mystery solved: Marine microbe is source of rare nutrient 2Mystery solved: Marine microbe is source of rare nutrient 3How the 100th protein structure solved at Diamond impacts our understanding of how insects smell 2How the 100th protein structure solved at Diamond impacts our understanding of how insects smell 3Agronomy Society welcomes USDA Mississippi River Basin Initiative 2
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... , Jan. 26 The following is a ... PharmAthene, regarding the Commission on the Prevention of Weapons of ... Card by the Commission on the Prevention of Weapons of ... America still remains vulnerable to bioterrorism.  Our Nation,s ability to ...
... , , TUALATIN, Ore. ... Bulletin Board: WYNX), a platform company dedicated to the ... announced that it has reached an agreement with British-based ... second generation Gas Quality Inferential Measurement Device (GasPT2). , ...
... Jan. 26 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... that it may now enroll patients at US clinical sites ... lead product, nimotuzumab. One of the two trials is in ... treatment and being treated palliatively and the other in patients ...
Cached Biology Technology:Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 2Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 3Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 4YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA 2YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA 3YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA 4YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA 5
Whole rabbit blood (any breed, either sex) is collected at the time of slaughter and processed immediately at 4C, bottled, frozen and stored at -70C....
Animal Origin Free...
Goat polyclonal to PINX1 ( Abpromise for all tested applications). entrezGeneID: 54984 SwissProtID: Q548A5...
Request Info...
Biology Products: